The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation  by Wang, Ruoning et al.
Immunity
ArticleThe Transcription Factor Myc Controls Metabolic
Reprogramming upon T Lymphocyte Activation
Ruoning Wang,1 Christopher P. Dillon,1,4 Lewis Zhichang Shi,1,4 Sandra Milasta,1 Robert Carter,2 David Finkelstein,2
Laura L. McCormick,1 Patrick Fitzgerald,1 Hongbo Chi,1 Joshua Munger,3 and Douglas R. Green1,*
1Department of Immunology
2Department of Information Sciences
St. Jude Children’s Research Hospital, Memphis, TN 38105, USA
3Department of Biochemistry and Biophysics, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
4These authors contributed equally to this work
*Correspondence: douglas.green@stjude.org
DOI 10.1016/j.immuni.2011.09.021SUMMARY
To fulfill the bioenergetic and biosynthetic demand
of proliferation, T cells reprogram their metabolic
pathways from fatty acid b-oxidation and pyruvate
oxidation via the TCA cycle to the glycolytic,
pentose-phosphate, and glutaminolytic pathways.
Twoof the top-rankedcandidate transcription factors
potentially responsible for the activation-induced
T cell metabolic transcriptome, HIF1a and Myc,
were induced upon T cell activation, but only the
acute deletion of Myc markedly inhibited activation-
induced glycolysis and glutaminolysis in T cells.
Glutamine deprivation compromised activation-
induced T cell growth and proliferation, and this
was partially replaced by nucleotides and poly-
amines, implicating glutamine as an important source
for biosynthetic precursors in active T cells. Meta-
bolic tracer analysis revealed a Myc-dependent
metabolic pathway linking glutaminolysis to the
biosynthesis of polyamines. Therefore, aMyc-depen-
dent global metabolic transcriptome drives meta-
bolic reprogramming in activated, primary T lympho-
cytes. This may represent a general mechanism for
metabolic reprogramming under patho-physiological
conditions.
INTRODUCTION
Proliferating animal cells consume considerable amounts of
energy and require de novo synthesis of macromolecules to
support their growth and proliferation (DeBerardinis et al.,
2008; Newsholme et al., 1985b). Consequently, one of the funda-
mental problems in animal cells is coordination of the metabolic
program with cell growth- and proliferation-associated bioener-
getic demand (Jorgensen and Tyers, 2004). Whereas prokary-
otes and unicellular eukaryotes rely primarily on homeostatic
regulation of cell metabolism, metabolic programs in multicel-
lular eukaryotes have evolved to be actively controlled by extra-
cellular signals (Deberardinis et al., 2008).
Upon stimulation of antigen receptors, quiescent naive T cells
undergo a growth phase of 24 hr, followed by massive clonalIexpansion and differentiation phases that are essential for
appropriate immune defense and regulation. During prolifera-
tion, T cells can undergo a cell division every 4–6 hr (van Stip-
donk et al., 2003). Coinciding with the clearance of antigen,
effector T cells undergo an abrupt contraction phase in which
the majority of T cells are eliminated by apoptosis (Green,
2003; Schumacher et al., 2010). Accumulation of cell biomass
during the initial growth and rapid proliferation during the expan-
sion phase is associated with dramatically increased bioener-
getic and biosynthetic demand. Thus, T cell activation provides
a unique physiological cellular model to help us understand
how animal cells coordinate their metabolic program with cell
growth and proliferation in response to extracellular fate-deci-
sive signals.
Early studies showed that polyclonal mitogens such as conca-
navalin A and phytohaemagglutinin drive the upregulation of
glycolysis and glutamine oxidation in thymocytes and mature
lymphocytes (Brand et al., 1984; Newsholme et al., 1985b).
Consistent with these observations, the uptake of glutamine
and glucose and the consumption of the latter, mainly through
glycolysis, are substantially upregulated upon stimulation with
anti-CD3 and anti-CD28 (Carr et al., 2010; Frauwirth et al.,
2002). Signaling via ERK and AKT pathways has been implicated
in the uptake of glutamine and glucose, respectively (Carr et al.,
2010; Frauwirth et al., 2002; Wofford et al., 2008), and the
mammalian target of rapamycin (mTOR), an essential compo-
nent of PI3K-Akt pathway, has recently been implicated in regu-
lating fatty acid metabolism in memory T cells (Pearce et al.,
2009; Araki et al., 2009). However, the robustness of metabolic
changes after T cell activation suggests the presence of addi-
tional regulatory steps in the T cell metabolic program, and the
molecular mechanisms behind these remain to be explored.
The metabolic changes associated with T cell activation are
reminiscent of the characteristic metabolic activities of tumor
cells and may represent a general metabolic reprogramming
during cell growth and proliferation (Kim and Dang, 2006; Vander
Heiden et al., 2009; Warburg, 1956).
RESULTS
T Cell Activation Induces Metabolic Reprogramming
To understand how T cells reprogram metabolic pathways to
fulfill the bioenergetic and biosynthetic demand for the burst of
proliferation upon activation, we used a well-established ex vivommunity 35, 871–882, December 23, 2011 ª2011 Elsevier Inc. 871
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without a requirement for additional cells. Freshly isolated
murine primary T cells were either maintained in interleukin 7
(IL-7) (hereafter ‘‘resting T cells’’) (Vella et al., 1997) or were stim-
ulated with anti-CD3 plus anti-CD28 (hereafter ‘‘active T cells’’).
After activation, both CD4+ and CD8+ T cells increased their cell
size over a 24 hr period (Figure S1A available online) followed by
rapid cell division over the ensuing 24–72 hr (Figure S1B). This
provided a 24 hr ‘‘window’’ in which to interrogate changes in
metabolism upon activation, without the potentially confounding
effects of proliferation.
We applied a mass-spectrum-based metabolomic approach
to determine the relative intracellular concentration of metabo-
lites in T cells after activation. Although at an early time point
(6 hr after activation), activated T cells contained lower amounts
ofmetabolites than resting T cells, T cells that had been activated
for longer times (24 and 30 hr) accumulated markedly higher
amounts of metabolites involved in the anabolic pathways of
lipids, amino acids, and nucleotides (Figure 1A; Table S1). This
may reflect cell growth before entering into the cell cycle (Fig-
ure S1A). In contrast, carnitines, which are required for fatty
acidb-oxidation,weredownregulatedafter activation (Figure 1A).
Consistent with earlier studies (Frauwirth et al., 2002), activa-
tion of T cells dramatically upregulated glycolysis (Figure 1B).
In contrast, both mitochondria-dependent fatty acid b-oxidation
(FAO) and pyruvate oxidation through the tricarboxylic acid
cycle (TCA cycle) were markedly downregulated upon activa-
tion (Figures 1C and 1D). Similarly, glutamine consumption
through oxidative catabolism was significantly upregulated
upon activation (Figure 1E), as suggested by earlier observations
(Newsholme et al., 1985a). Glucose consumption via the pentose
phosphate pathway (PPP) (Figure 1F) and oxygen consumption
(Figure S1C) were also significantly elevated in activated
T cells. Therefore, activation rapidly switches T cell metabolism
from FAO and pyruvate oxidation via the TCA cycle to aerobic
glycolysis, PPP, and glutamine oxidation (hereafter ‘‘activation-
induced metabolic reprogramming’’).
Glucose and Glutamine Catabolism Are Required
for Activation-Induced T Cell Proliferation In Vitro
and In Vivo
To explore the impact of metabolic reprogramming on T cell
growth and proliferation, we stimulated T cells in either complete
or nutrient-free media. Whereas deprivation of glutamine but not
glucose led to an impairment of activation-induced cell growth
(Figure S1D) associated with a reduction of lipid and protein
biosynthesis (Figures S1E and S1F), neither condition affected
viability or appearance of the activation markers CD25 and
CD69 (Figures S1G and S1H). However, both conditions resulted
in impaired activation-induced cell proliferation (Figure S1I).
Consistent with previous work (Rowell and Wells, 2006), T cell
activation was associated with downregulation of the cell cycle
inhibitor p27, the upregulation of cyclins and cyclin-dependent
kinases (CDKs), and the appearance of markers of S phase,
such as the phosphorylation of RB and Cdc6 (Figure S1J).
The stabilization of p27 and the absence of S phase markers
indicated a G1 cell cycle arrest under glutamine starvation.
However, the similar expression and phosphorylation pattern
of cell cycle regulators in control and glucose-starved cells sug-872 Immunity 35, 871–882, December 23, 2011 ª2011 Elsevier Inc.gested that glucose deprivation might inhibit cell proliferation
through a mechanism distinct from that of glutamine starvation.
We next applied a panel of potent chemical inhibitors targeting
different metabolic pathways. Inhibition of FAO by the carnitine
palmitoyltransferase-I (CPT-I) inhibitor Etomoxir (Eto) did not
affect T lymphocyte proliferation (Figure S1K), consistent with
the low FAO flux in active T cells. In contrast, the hexokinse
(HK) inhibitor 2-deoxy-D-glucose (2DG), the glucose-6-phos-
phate dehydrogenase (G6PD) inhibitor dehydroepiandrosterone
(DHEA), the glutaminase (Gls) inhibitor 6-diazo-5-oxo-l-norleu-
cine (DON), or the transaminase inhibitor aminooxyacetate
(AOA), each of which inhibits activation-induced metabolic path-
ways, blocked T cell proliferation (Figure S1K).
To further test the dependency of T cell proliferation on
glucose and glutamine catabolism in vivo, we applied 2DG and
DON in an adoptive transfer model by using ovalbumin (OVA)-
specific, TCR-transgenic OT-II T cells (Figure 1G; Shi et al.,
2011). In agreement with our in vitro results, both 2DG and
DON partially inhibited the proliferation of antigen-specific active
T cells after OVA immunization in vivo (Figure 1H). Therefore,
both glucose and glutamine catabolic pathways are required
for activation-induced T cell proliferation in vitro and in vivo.
T Cell Metabolic Reprogramming Is Associated with
Global Changes in the Metabolic Gene Transcriptome
Antigen activation of T lymphocytes drives distinct transcrip-
tional programs including upregulation of cell cycle and cytokine
genes (Lu et al., 2004; Teague et al., 1999). Real-time quantita-
tive PCR (qPCR) analysis revealed a time-dependent upregula-
tion of mRNAs encoding metabolic enzymes and transporters
involved in glycolysis (Figure 2A) and in both arms of the PPP
(Figure S2A). Notably, only one member in each metabolic
enzyme gene family was selectively upregulated (Figure 2A).
Immunoblot analysis further confirmed the upregulation of
selected metabolic genes at the protein level (Figure S2B).
Glutamine catabolism is not only tightly coupled to different
biosynthetic pathways but also generates the anaplerotic
substrate a-ketoglutarate (a-KG), which can be metabolized
through the TCA cycle to generate either citrate or pyruvate
(‘‘glutaminolysis’’) (Newsholme et al., 1985a). Whereas the
conversion of glutamine (Gln) to glutamate (Glu) is controlled
by glutamine-fructose-6-phosphate transaminase 1 (Gfpt1), car-
bamoyl-phosphate synthetase (CAD), phosphoribosyl pyro-
phosphate amidotransferase (Ppat), and glutaminase 2 (Gls2),
the conversion of glutamate to a-KG is controlled by glutamate
dehydrogenase 1 (Glud1), glutamate oxaloacetate transaminase
(Got), and ornithine aminotransferase (Oat). Consistent with the
idea that a-KG is an anaplerotic substrate of the TCA cycle,
metabolic enzymes in the TCA cycle including isocitrate dehy-
drogenase-3 (IDH3), malate dehydrogenase (MDH), succinate
dehydrogenase complex subunit C (SDHc), and malic enzyme
2 (ME2) were also upregulated (Figures 2B, S2A, and S2B).
We compared our metabolic gene expression data of active
mouse T lymphocytes with metabolic gene expression data
from a recently published microarray study of active human T
lymphocytes (Wang et al., 2008). A marked correlation between
these two data sets, indicated by the Spearman rank-order
correlation coefficient, suggests that metabolic genes in acti-
vated human T lymphocytes are similarly regulated (Figure S2C).
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Figure 1. Stimulation of TCR and CD28 Drives T Cell Metabolic Reprogramming
(A) Intracellular metabolites in T cells collected at the indicated times after activation were profiled by mass spectroscopy. The value for each metabolite
represents the average of triplicates and the amount of each metabolite in resting T cells was set to 1. The heat map represents the log2 value of the relative
amount of eachmetabolite, which was grouped in the indicated metabolic pathways (see color scale). The complete metabolomic profile is provided in Table S1.
(B–F) Metabolic assays, with the isotopically labeled tracer used highlighted in red (left). Resting T cells (Rest) and activated T cells (collected at 24 hr after
activation in D–F or at the indicated times after activation in B andC) were used for measuring the generation of 3H2O from [3-
3H]-glucose (glycolysis, right panel in
B) or from [9,10-3H]-palmitic acid (FAO, right panel in C); the generation of 14CO2 from [2-
14C]-pyruvate (TCA, right panel in D), from [U-14C]-glutamine (gluta-
minolysis, right panel in E), or from [1-14C]-glucose (PPP, right panel in F). Error bars represent standard deviation from the mean of triplicate samples. Data are
representative of three independent experiments.
(G) Overview of the experimental procedure used for assessing OT-II T cell proliferation in vivo (H).
(H) Naive OT-II T cells (CD45.1+) were CFSE labeled and transferred into C57BL/6 mice, which were immunized with OVA and treated daily with the indicated
inhibitors or vehicle controls. Splenocytes were analyzed 3 days after immunization and OT-II cell proliferation was determined by flow cytometry.
Data represent two independent experiments. See also Figure S1.
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Myc-Driven Metabolism in T Cell ActivationTaken together, these results are consistent with our metabolic
flux data and indicate that global regulation of metabolic gene
transcription is involved in activation-induced T cell metabolic
reprogramming.IMyc, but Not HIF1a, Is Required for Activation-Induced
T Cell Metabolic Reprogramming
With an in silico approach (Roider et al., 2009), transcription
factors possibly involved in activation-induced T cell metabolicmmunity 35, 871–882, December 23, 2011 ª2011 Elsevier Inc. 873
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Figure 2. T Cell Activation Drives the Transcription of a Distinct Set of Metabolic Genes
(A andB) The glycolytic pathway (left in A) and the glutaminolytic pathway (left in B), with themetabolic genesmeasured highlighted in blue. RNAwas isolated from
T cells collected at the indicated times after activation and used for qPCR analyses of metabolic genes in the glycolytic pathway (right in A) and the glutaminolytic
pathway (right in B). mRNA levels in resting T cells were set to 1. The heat map represents the log2 value of the relative mRNA expression level (see color scale).
Values and standard deviations are provided in Table S2. Data are representative of two independent experiments.
(C) The top ten predicted corresponding transcription factors and motifs were ranked in descending order of association score, which indicates the likelihood of
the binding of a particular transcription factor to the input gene promoters correlating with the expression levels. The input gene list and expression profile is
provided in Table S3.
(D–G) Protein and mRNA expression of HIF1a (D and E, respectively) and of Myc (F and G, respectively) in T cells collected at the indicated times after activation
were determined by immunoblot and qPCR. mRNA levels in resting T cells were set to 1. Error bars represent standard deviation from the mean of triplicate
samples. Data are representative of two independent experiments.
See also Figure S2.
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Myc-Driven Metabolism in T Cell Activationreprogramming were ranked by the likelihood of a particular
transcription factor binding to the input gene promoters (Fig-
ure 2C; Table S3). Among the top ten candidates (Figure 2C),
hypoxia inducible factor 1, alpha subunit (HIF1a), and myelocy-
tomatosis oncogene (Myc) were chosen for further investiga-
tion. Both HIF1a and Myc were recently suggested to regulate874 Immunity 35, 871–882, December 23, 2011 ª2011 Elsevier Inc.cell metabolism in transformed cells (Dang and Semenza,
1999; Gordan et al., 2007) and were highly induced at both the
transcription and protein levels upon T cell activation (Figures
2D–2G). The induction of these two transcription factors
preceded the induction of most metabolic genes examined
(Figures 2A and 2B) and the upregulation of glycolysis and
Immunity
Myc-Driven Metabolism in T Cell Activationglutaminolysis (Figures 1B and 1E). In contrast, the unperturbed
expression of the endogenous Myc antagonist Mad suggests
that this may not be instrumental in the observed changes
(Figure S2D).
Early studies have implicated the involvement of ERK-, AKT-,
and mTOR-mediated signaling pathways in regulating T cell
metabolism (Carr et al., 2010; Frauwirth et al., 2002; Pearce
et al., 2009). We next applied a panel of potent chemical inhibi-
tors targeting different activation-induced signaling pathways
and followed the expression of Myc and HIF1a. Inhibition of
any of these kinases significantly reduced the induction of Myc
and HIF1a after T cell activation (Figure S2F), which was associ-
ated with the reduction of glycolytic activitiy (Figure S2E). There-
fore, ERK-, AKT-, and mTOR-mediated signaling pathways may
regulate T cell metabolism at least partially through regulating
the expression of Myc and HIF1a.
We generated a mouse model carrying a conditional HIF1a
allele (Hif1aflox/flox) and a tamoxifen-inducible Cre recombinase
(CreERT2) transgene (de Luca et al., 2005; Ryan et al., 2000) to
delete HIF1a flox alleles in an acute manner. Freshly isolated
T cells were cultured with IL-7 for 2 days with or without
4-Hydroxytamoxifen (4OHT), following which cells were either
maintained in IL-7 (resting) or activated with anti-CD3 and anti-
CD28 (active) (Figure S3A). As controls, comparable cell prolifer-
ation and glycolytic rate were observed in T cells containing the
CreER transgene only, and treated with vehicle or 4OHT (Figures
S3B and S3C). Efficient deletion of HIF1a was observed at the
protein (Figure 3A) andmRNA (Figure 3B) levels after 4OHT treat-
ment. However, glycolysis, glutaminolysis, and FAO were unaf-
fected by acute HIF1a deletion 24 hr after T cell activation
(Figures 3C, 3D, and S3E). Whereas the induction of two known
HIF1a target genes, LDHa andHK2, wasmoderately impaired by
the deletion of HIF1a, the expression of other activation-induced
metabolic genes was comparable in WT and HIF1a-deficient
T cells (Figure S3F). Moreover, activation-associated cell prolif-
eration (Figure 3E), cell growth (Figure 3F), and cell surface
appearance of the activation marker CD25 (Figure S3D) were
unaffected in HIF1a-deficient cells, and mild impairment of
glycolysis was observed only at 72 hr postactivation (Fig-
ure S3G). Therefore, HIF1a is not required for activation-induced
metabolic reprogramming prior to T cell proliferation, but may be
involved in optimally maintaining T cell glycolytic activities after
entry into the cell cycle.
We then generated mice carrying a conditional Myc allele
(Mycflox/flox) and a tamoxifen-inducible Cre recombinase
(CreERTam) (Badea et al., 2003; de Alboran et al., 2001). After
addition of 4OHT, efficient deletion of the Myc gene was
observed at the protein (Figure 4A) and mRNA (Figure 4B) levels.
Although Myc was suggested to be required for T cell prolifera-
tion and growth under most experimental conditions (Dose
et al., 2006; Iritani et al., 2002), one study indicated that it is
essential for cell proliferation but not cell growth (Trumpp
et al., 2001). We found that acute deletion of Myc blocked acti-
vation-associated cell proliferation and growth in vitro (Figures
4C and 4D). Metabolomic profiling further revealed that Myc-
deficient T cells accumulated significantly lower levels of lipids,
amino acids, and nucleotides (Figure 4E). We then examined the
role of Myc in regulating T cell proliferation and growth in vivo in
response to staphylococcal enterotoxin B (SEB) (Figure 4F),Iwhich as a superantigen engaged sufficiently large numbers of
naive Vb8+ T cells to perform metabolic studies (see below).
Consistent with our in vitro results, the in vivo deletion of Myc
blocked SEB-induced Vb8+ T cell proliferation and growth
(Figures 4G and 4H). We observed that acute depletion of
Myc, in vivo, did not compromise the health of the animals
over a period of 1 week, consistent with a recent report (Soucek
et al., 2008).
Myc regulates cell cycle progression either directly or indi-
rectly through controlling the expression of several essential
cell cycle regulators including p27, cyclins, and CDKs (Dang
et al., 2006; Eilers and Eisenman, 2008). Whereas the downre-
gulation of p27 and upregulation of Cyclin D3 were largely
undisturbed, induction of Cyclin A, cdk2, cdk4, and cdc25a
were impaired to varying degrees in Myc-deficient T cells (Fig-
ure S4A). Phosphorylation of RB and Cdc6, two S phase
markers, was delayed and abolished, respectively (Figure S4A).
In contrast, the upregulation of the activation markers CD69
and CD25 (Figure S4B) was comparable between Myc-defi-
cient and WT cells, as was the phosphorylation of AKT and
ERK (Figure S4C). The expression of several cytokines was
unaffected or elevated in Myc-deficient cells (Figures S4D
and S4E). Thus, the general signaling pathways mediated by
TCR and cytokines are largely intact in T cells lacking Myc,
and the acute deletion of Myc abrogates activation-induced
T cell growth and proliferation but not other activation-induced
events in T cells.
Myc-Dependent Induction of Glucose Metabolic Genes
Drives Glucose Catabolism
Deletion of Myc significantly impaired activation-induced glyco-
lytic flux at both early and late time points (Figures 5A and S5A).
Consistent with this, intracellular lactate in Myc-deficient T cells
was lower than in WT control cells (Figure S5B). Moreover, the
partial reduction of Myc expression in T cells containing hetero-
zygousMycflox/wt alleles led to a moderate impairment of activa-
tion-induced glycolysis (Figures S5C and S5D). This suggests
that the maximum expression of Myc is required for the
maximum increase in glycolysis after activation of T cells. The
upregulation of several glycolytic enzymes and transporters
was impaired to varying degrees in Myc-deficient T cells upon
activation (Figure 5B). Further, Myc deficiency led to a reduction
of HK2 and pyruvate kinase muscle isoform 2 (PKM2) at the
protein level (Figure S5F). Finally, we tested the relevance of
Myc in regulating T cell metabolism in response to SEB, as
described above (Figure 4F). Consistent with our in vitro results,
Myc is required for the induction of enhanced glycolytic activity
and metabolic gene expression in SEB-responsive T cells in vivo
(Figures 5C and 5D).
Because glycolysis interconnects with other metabolic path-
ways, such as the PPP, the TCA cycle, and FAO, we investigated
the metabolic flux through these pathways. Acute deletion of
Myc moderately inhibited activation-induced upregulation of
metabolic activity through the PPP (Figure 5E), and the induction
of two key metabolic enzymes in the PPP, Tkt and G6PDx, was
compromised in Myc-deficient T cells upon activation (Fig-
ure S5E). In contrast, pyruvate metabolic flux, FAO flux, and
oxygen consumption rates were unaffected by Myc deletion
(Figures 5F, S5G, and S5H).mmunity 35, 871–882, December 23, 2011 ª2011 Elsevier Inc. 875
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Figure 3. HIF1a Is Not Required for Activation-Induced Metabolic Reprogramming
(A and B) T cells were isolated from RosaCreERT2/HIF1aflox/flox mice and pretreated with vehicle (WT) or with 500 nM 4OHT (KO). HIF1a protein and mRNA levels
in T cells collected at the indicated times after activation were determined by immunoblot (A) and qPCR (B). mRNA levels in resting WT T cells were set to 1.
(C and D) Glycolysis and glutaminolysis as determined by the generation of 3H2O from [3-
3H]-glucose (C) and the generation of 14CO2 from [U-
14C]-glutamine (D),
respectively.
Error bars in (B)–(D) represent standard deviation from the mean of triplicate samples. Data are representative of two independent experiments.
(E) Cell proliferation of resting (Rest), active WT, and KO T cells (48 hr) was determined as CFSE dilution.
(F) Cell size of resting (Rest), active WT, and KO T cells (24 hr) was determined as forward light scatter.
See also Figure S3.
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Myc-Driven Metabolism in T Cell ActivationMyc-Dependent Glutaminolysis Cross-talks
with the mTOR Pathway
Deletion of Myc profoundly inhibited the upregulation of gluta-
mine oxidation in active T cells (Figure 6A). Recent studies in
human cell lines have suggested that enforced expression of
Myc regulates the rate-limiting glutaminolyic enzyme gluta-
minase 1 (Gls1) through both transcription and posttranscrip-
tional mechanisms (Gao et al., 2009; Wise et al., 2008), and
p53 regulates the transcription of glutaminase 2 (Gls2) (Hu
et al., 2010; Suzuki et al., 2010). We observed that neither the
mRNA nor protein levels of Gls1 were elevated upon T cell acti-876 Immunity 35, 871–882, December 23, 2011 ª2011 Elsevier Inc.vation (Figures 2B and S2B), whereas the transcription and
translation of glutaminase 2 (Gls2) along with other metabolic
genes in glutamine catabolic pathways were induced in a Myc-
dependent manner in vitro and in vivo (Figures 5D, 6B, and
S5F). However, we found that p53 was dispensable for the
induction of Gls2 and glutaminolysis upon T cell activation
(Figures 6D and 6E).
Either glutamine starvation or Myc deletion was sufficient
to abrogate activation-induced T cell growth (Figures S1D,
S4D, and S4H). Because glutamine flux might regulate cell
growth through the mTOR pathway (Nicklin et al., 2009),
A B
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Figure 4. Myc Is Required for T Cell Growth and
Proliferation
(A) T cells isolated from either RosaCreERTam-MycWT/WT
mice (WT) or RosaCreERTam-Mycflox/flox mice (flox/flox)
were pretreated with vehicle (4OHT) or with 500 nM
4OHT (+4OHT). Myc protein levels were determined by
immuoblot.
(B) Myc mRNA levels in T cells collected at the indicated
times after activation as determined by qPCR. mRNA
levels in resting WT T cells were set to 1. Error bars
represent standard deviation from the mean of triplicate
samples. Data are representative of two independent
experiments.
(C) Cell proliferation of active T cells (48 hr) was determined
as CFSE dilution.
(D) Cell size of resting (Rest) and active T cells (24 hr) was
determined as forward light scatter.
(E) The level of intracellular metabolites in the indicated
samples; the value of each metabolite was obtained from
the average of triplicates and the level of each metabolite
in restingWT T cells was set to 1. The heat map represents
the log2 value of the relative level of each metabolite,
which was grouped in the indicated metabolic pathway
(see color scale). The complete metabolomic profile is
provided in Table S6.
(F–H) The experimental procedure (F) used for the SEB
superantigen challenge model. Mycflox/flox mice (WT) or
RosaCreERTam-Mycflox/flox mice (KO) were treated with
tamoxifen (i.p. 1 mg/mouse for 3 days), and then were
injected with SEB (i.v. 100 mg/mouse). The percentage (G)
and the cell size (H) of Vb8+ T cells were determined 2 days
after injection of SEB.
See also Figure S4.
Immunity
Myc-Driven Metabolism in T Cell Activationglutamine-dependent modulation of mTOR activation might
partially account for the regulation of T cell growth by Myc.
Whereas the phosphorylation kinetics of upstream components
(mTOR and AMPK) were unaffected, acute deletion of Myc
impaired the activation of downstream effectors in the mTOR
pathway, as indicated by the reduction of phosphorylation of
P70K and the reduction of phosphorylation and protein levels
of 4E-BP and S6 in Myc-deficient cells (Figure S6A). Consistent
with an indispensable role for the glutamine antiporter CD98,
a heterodimer of Slc3a2/Slc7a5, in modulating the mTOR
pathway (Nicklin et al., 2009), both the transcription of Slc3a2/
Slc7a5 and the cell surface appearance of CD98 were impaired
in Myc-deficient T cells upon activation in vitro and in vivo
(Figures 6B, 6C, S6C, and 5D). Moreover, glutamine starvation
largely recapitulated the impairment of the activation of down-
stream effectors in the mTOR pathway as observed in Myc-defi-
cient cells (Figure S6B). These results demonstrate an essential
role for Myc in the upregulation of glutaminolysis upon activation
and imply that cross-talk with the mTOR pathway via amino acid
uptake may be involved in the Myc-dependent regulation of
T cell growth.Immunity 35, 871–Myc-Driven Glutamine Catabolism
Couples with Multiple Biosynthetic
Pathways
Myc drives the expression of Gfpt1, Cad, Ppat,
and Oat (Figures 2B and 6B), which not only
are required for glutaminolysis but also controlcritical steps in the hexosamine, pyrimidine, purine, and poly-
amine biosynthetic pathways (Figure 2B, left). Although we failed
to detect any intermediate metabolites in the hexosamine
biosynthetic pathway because of technical limitations, the levels
of intermediate metabolites in the polyamine and nucleotide
synthetic pathways were lower in Myc-deficient cells (Figures
S6D and S6E; Table S6). Consistent with a previous study
(Bowlin et al., 1987), difluoromethylornithine (DFMO), a potent
inhibitor of ornithine decarboxylase (ODC) and polyamine
biosynthesis, inhibited activation-induced T cell proliferation
in vitro and in vivo (Figure 6F and 1H), and the addition of exog-
enous polyamines completely restored proliferation in the pres-
ence of DFMO in vitro (Figure 6F).
Addition of either hypoxanthine and thymidine (HT) or poly-
amines (PAs) alone was insufficient to permit cell proliferation
in the absence of glutamine (Figure S7A). Because a-KG is
required to maintain cell viability and minimal cell proliferation
in the absence of glutamine (Wise et al., 2008), addition of
a-KG alone was sufficient to drive only one cell division in the
absence of glutamine. However, the combination of a-KG with
either HT or with PAs promoted additional cell divisions and882, December 23, 2011 ª2011 Elsevier Inc. 877
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Figure 5. Myc Drives a Transcription Program
that Regulates Glucose Catabolism upon T Cell
Activation
(A) Glycolytic flux as determined by the generation of 3H2O
from [3-3H]-glucose.
(B) qPCR analyses of metabolic genes. mRNA levels in
resting WT T cells were set to 1. The heat map represents
the log2 value of the relative mRNA expression level (see
color scale). Values and standard deviations are provided
in Table S5. Data are representative of two independent
experiments, performed in triplicate.
(C and D) Naive CD4+Vb8+ T cells (R) were sorted from
mice without SEB immunization; WT and acutely Myc-
deleted CD4+Vb8+ T cells (KO) were isolated from mice
2 days after SEB immunization (Figure 4F). Glycolysis (C)
and mRNA expression (D and Table S5) in the indicated
groups were determined by the generation of 3H2O from
[3-3H]-glucose and qPCR, respectively.
(E and F) PPP flux (E) and pyruvate oxidation through the
TCA cycle (F) were determined by the generation of 14CO2
from [1-14C]-glucose and from [2-14C]-pyruvate, respec-
tively.
Error bars in (A), (E), and (F) represent standard deviation
from the mean of triplicate samples. See also Figure S5.
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Myc-Driven Metabolism in T Cell Activationgrowth (Figures 6G andS7B). Consistent with a direct role ofMyc
in regulating cell proliferation (Dang et al., 2006; Eilers and Eisen-
man, 2008), addition of a-KG with HT and PAs failed to promote
cell proliferation in Myc-deficient T cells (Figure S7C). Taken
together, our results indicate that Myc-driven glutaminolysis
coordinates multiple biosynthetic pathways to support activa-
tion-induced cell proliferation and growth.
A Myc-Dependent Metabolic Pathway Linking
Glutaminolysis to Ornithine and Polyamine Biosynthesis
Although ornithine is produced largely from arginine via the
action of arginase as part of the urea cycle (Morris, 2004), urea
cycle enzymes including arginase were not induced upon activa-
tion (Figure S7D) nor were any defects in proliferation observed
in T cells lacking arginase I (Figures 7A and 7B), the dominant
isoform in the thymus (Yu et al., 2003). These results indicate
that arginine is not the only precursor for ornthine in T cells.
Previous studies in bovine endothelial and intestinal epithelial
cells suggested the possible presence of a noncanonical meta-
bolic pathway, which generates ornithine from glutamine (Wu
et al., 2000; Wu and Morris, 1998). This putative pathway is
composed of two key steps: aldehyde dehydrogenase 18 family878 Immunity 35, 871–882, December 23, 2011 ª2011 Elsevier Inc.member A1 (Aldh18a1) converts glutamate
to (S)-1-pyrroline-5-carboxylate (P-5-C), after
which OAT converts P-5-C to ornithine (Fig-
ure 7C). Alternatively, proline has also been
suggested as a source for ornithine through
a two-step reaction involving proline dehydro-
genase (Prodh) and OAT (Phang et al., 2008).
Intriguingly, the metabolic enzymes Aldh18A1,
Prodh, and OAT that link glutamine and proline
to ornithine synthesis were induced in a Myc-
dependent manner upon T cell activation
(Figures 7C and S5F), as were the metabolic
enzymes, ODC, spermine synthase (SRM), andspermidine synthase (SMS), that convert ornithine to polyamines
(Figure 7C). Therefore, we followed U-13C-isotope labeled gluta-
mine (U-13C-glutamine) flux and observed the incorporation of
13C into all five carbons of ornithine (U-13C-ornithine), which
accounted for up to 30% of total ornithine in active T cells but
only 1% in resting T cells (Figure S7E). Finally, deletion of Myc
partially abolished the incorporation of glutamine-derived
carbons into both ornithine and putrescine (Figure 7D). Taken
together, our results indicate a Myc-dependent noncanonical
ornithine biosynthetic pathway coupling glutaminolysis to orni-
thine and polyamine biosynthesis in activated T cells (Figure 7E).
DISCUSSION
Extracellular signals play an essential role in dictating eukaryotic
cell growth, proliferation, and metabolism. TCR- and costimula-
tor-mediated signals drive T cell growth and clonal expansion,
and coordinately reprogram metabolic cascades to fulfill the
ensuing bioenergetic and biosynthetic demands (Fox et al.,
2005; Krauss et al., 2001). Although ectopic overexpression of
Myc in transformed cell lines coordinately drives cell proliferation
and proliferation-associated metabolic activities, including the
A D
E
B
F
G
C
Figure 6. Myc Drives a Transcriptional Program
Coupling Glutaminolysis to Biosynthetic Pathways
(A) Rates of glutaminolysis, determined by the generation
of 14CO2 from [U-
14C]-glutamine. Data are representative
of two independent experiments.
(B) qPCR analyses of metabolic genes. mRNA levels in
resting WT T cells were set to 1. The heat map represents
the log2 value of the relative mRNA expression level (see
color scale). Values and standard deviations are provided
in Table S5. Data are representative of two independent
experiments.
(C) Cell surface expression of CD98 was determined by
flow cytometry.
(D) Protein levels of Gls2 and p53 were determined by
immunoblot. The asterisk indicates a nonspecific band.
(E) Glutaminolytic fluxwas determined by the generation of
14CO2 from [U-
14C]-glutamine.
(F) Cell proliferation of active T cells (48 hr), treated with
vehicle (Ctr), with 1 mM DFMO (Inh) or with 1 mM DFMO
plus polyamine mixture (Inh/PAs), determined by CFSE
dilution. The composition and concentration of polyamine
mixture are provided in Table S7.
(G) T cells were collected at 72 hr after activation in
glutamine-free media (Q-), in glutamine-free media sup-
plemented with 2 mM a-KG (Q-/aKG), in glutamine-free
media supplemented with 2 mM a-KG and 100 mM hypo-
xanthine and 16 mM thymidine (Q-/aKG/HT), or in gluta-
mine-free media supplemented with 2 mM a-KG and
polyamine mixture (Q-/aKG/PAs). The composition and
concentration of the polyamine mixture is provided in
Table S7. Cell proliferation was determined as CFSE
dilution by flow cytometry.
Error bars in (A) and (E) represent standard deviation from
the mean of triplicate samples. See also Figure S6.
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Myc-Driven Metabolism in T Cell Activationcatabolism of glucose and glutamine (Dang and Semenza, 1999;
Gordan et al., 2007), whether the induction of endogenous Myc
upon physiological stimulation plays a similar role has not been
explored. We show that the activation of T cells rapidly switches
metabolic programs from fatty acid b-oxidation and pyruvate
oxidation via the TCA cycle to aerobic glycolysis, PPP, and glu-
taminolysis. This metabolic reprogramming is associated with
a global change in the metabolic transcriptome, which follows
the induction of endogenous Myc and HIF1a upon activation.
Based on the effects of acute genetic ablation of these transcrip-
tion factors, we identified Myc as a critical metabolic reprogram-
ming factor in T cells. Our studies shed light on the complex utili-
zation of metabolic resources, pathways, and intermediates that
rationalize the strict dependence of T cell growth and prolifera-
tion on glutaminolysis and indicate a glutaminolysis- and Myc-
dependent de novo polyamine biosynthetic pathway essential
for T cell proliferation. Whereas previous studies clearly demon-
strate that Myc directly regulates T cell proliferation mainly
through transcriptional control of cell cycle regulators (Dose
et al., 2006; Iritani et al., 2002), our studies implicate Myc as an
essential coordinator of T cell activation-induced cell growth,
proliferation, and several aspects of metabolic reprogramming.Immunity 35, 871–T cell activation-induced glycolysis and gluta-
minolysis is reminiscent of the metabolic
changes in tumor cells, where both aerobic
glycolysis (the Warburg effect) and glutaminoly-sis are driven by aberrant oncogenic signals (Dang and
Semenza, 1999; Vander Heiden et al., 2009). Notably, ectopic
overexpression of Myc not only alters the transcription of several
glycolytic genes but also preferentially switches the expression
of PKM1 to PKM2 by modulating the alternative splicing of the
PKM transcript (Dang and Semenza, 1999; David et al., 2010).
Although the transcription of metabolic enzymes and trans-
porters involved in almost every step of glycolysis including
PKM2 are induced in a Myc-dependent manner upon T cell
activation, whether active T cells preferentially express PKM2
through alternative splicing remains to be determined. In
contrast, the metabolic program associated with glutaminolysis
in tumor cell lines and activated T cells is slightly different. In
tumor cells, Myc controls glutamine uptake through transcription
of SLC3a2, SLC5A1, and SLC7A1 and regulates the conversion
of glutamine to glutamate through both transcriptional and
posttranslational regulation of GLS1 (Gao et al., 2009; Wise
et al., 2008). Corresponding steps in active T cells, however,
are controlled by Myc-mediated transcription of SLC32a1,
SLC32a2, and GLS2. Although recent studies indicate that the
tumor suppressor p53 is required for the induction of GLS2 in
a human tumor cell line (Hu et al., 2010; Suzuki et al., 2010),882, December 23, 2011 ª2011 Elsevier Inc. 879
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Figure 7. Myc-Driven Glutaminolysis Fuels Poly-
amine Biosynthesis upon T Cell Activation
(A) Arginase I WT and KO T cells were collected 48 hr after
activation (Act/WT and Act/KO, respectively). Cell prolif-
eration was determined by CFSE dilution.
(B) WT and arginase I KO active T cells were analyzed by
qPCR for arginase I mRNA expression.
(C) Top: Potential metabolic steps linked to the polyamine
biosynthetic pathway, with metabolic genes measured
highlighted in blue. Bottom: WT and Myc KO T cells were
collected at the indicated times after activation and qPCR
analyses of metabolic genes was performed. mRNA levels
in resting T cells were set to 1. The heat map represents
the log2 value of the relative mRNA expression level (see
color scale). Values and standard deviations are provided
in Table S5. Data are representative of two independent
experiments, performed in triplicate.
(D) T cells were cultured in media containing U-13C-
glutamine and collected at the indicated times after acti-
vation. The intracellular levels of ornithine and putrescine
including U-13C- and 12C-labeled forms were determined
by mass spectroscopy.
(E) Myc-dependent metabolic reprogramming upon T cell
activation, with upregulated metabolic pathways high-
lighted in red, downregulated metabolic pathways high-
lighted in black, and Myc-dependent metabolic genes
highlighted in blue.
Error bars in (B) and (D) represent standard deviation from
the mean of triplicate samples. See also Figure S7.
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Myc-Driven Metabolism in T Cell Activationwe have found that the upregulation of GLS2 in murine T cells is
p53 independent. Although the regulatory mechanisms involved
are slightly different, the resemblance of tumor-associated
and T cell activation-associated metabolic programs indicate
that a general metabolic switch is required to support cell
growth and proliferation in both pathological and physiological
situations.
Glutamine has long been known to be an indispensible nutrient
for proliferating cells (Kovacevic and McGivan, 1983). Enhanced
glutamine utilization in rat lymphocytes upon polyclonal mitogen
stimulation is responsible for providing precursors for nucleotide
biosynthesis (Newsholme et al., 1985a). Metabolic flux analysis
in a glioblastoma cell line further revealed that a major portion
of glutamine-derived nitrogen and carbon are incorporated into
amino acids and lactate, a fraction of which are secreted as
metabolic by-products (DeBerardinis et al., 2007). These find-
ings indicate that glutamine is an important nitrogen and carbon
donor for a variety of biosynthetic precursors. Supporting this
notion, we found that activation of T cells triggers a Myc-depen-
dent induction of glutaminolysis, which not only leads to the
production of a-KG in the TCA cycle but is also coupled to nucle-
otide biosynthesis. Furthermore, the depletion of intracellular
ornithine and polyamines inMyc-deficient activated T cells impli-880 Immunity 35, 871–882, December 23, 2011 ª2011 Elsevier Inc.cates a noncanonical, Myc-dependent poly-
amine biosynthetic pathway upon activation.
Early studies showed that overexpression of
Myc in transformed cell lines induces the
expression of ODC (Bello-Fernandez, et al.,
1993). Although the protein level of ODC was
not elevated, the mRNAs of all three metabolic
enzymes downstream of ornithine were inducedin a Myc-dependent manner upon T cell activation, leading to
a massive increase in polyamine synthesis. The Myc-dependent
induction of Aldh18a1, Prodh, and OAT further indicates a Myc-
dependent metabolic route upstream of ornithine that links
glutamine and possibly proline to ornithine. Consistent with
this, the Myc-dependent incorporation of 13C-labeled glutamine
carbon into ornithine after T cell activation indicates that
activated T cells may acquire an alternative Myc-dependent
pathway coupling glutaminolysis to polyamine biosynthesis to
meet the markedly increased polyamine demands required for
proliferation. Our results suggest that Myc-dependent glutamine
catabolism not only replenishes the intermediate metabolites of
the TCA cycle by producing the anaplerotic substrate a-KG, but
also coordinates with Myc-dependent glucose catabolism to
support amino acid, nucleotide, and lipid biosynthesis. In addi-
tion, glutamine catabolism is tightly coupled to the biosynthesis
of polyamines that are essential for T cell proliferation.
EXPERIMENTAL PROCEDURES
Animals
Hif1aflox/flox and p53-null mice on the C57BL/6 background were purchased
from the Jackson Laboratory (Jacks et al., 1994; Ryan et al., 2000) and
Hif1aflox/flox mice were crossed with ROSA26CreERT2 (de Luca et al., 2005).
Immunity
Myc-Driven Metabolism in T Cell ActivationMycflox/flox mice were obtained from F. Alt (Harvard) (de Alboran et al., 2001)
and were backcrossed five generations onto the C56BL/6 background before
breeding to ROSA26CreER(Tam) (Badea et al., 2003). QA Resulting offspring
were interbred to obtain experimental animals. Arg1flox/flox; Tie2Cre mice
that were backcrossed to the C57BL/6 background were obtained from
P. Murray (SJCRH, Memphis) (El Kasmi et al., 2008). Mice at 7–12 weeks of
age were used. All mice were kept in specific-pathogen-free conditions within
the Animal Resource Center at St. Jude Children’s Research Hospital. Animal
protocols were approved by the Institutional Animal Care and Use Committee
of St. Jude Children’s Research Hospital.
RNA Isolation, Reverse Transcription, and qPCR
Total RNA was isolated with the RNeasy Mini Kit (QIAGEN) and was reverse
transcribed with random hexamer primers and M-MLV Reverse Transcriptase
(Invitrogen). Real-time qPCR for cytokines was performed with a TaqMan Low
Density Array (4367786, ABI). The comparison of cytokine gene expression in
resting and active T cells was visualized as heat maps with Cluster (Eisen and
Brown, 1999) and TreeView (Eisen et al., 1998). SYBR Green-based quantita-
tive RT-PCR for other genes was performed with the Applied Biosystems 7900
Real Time PCR System. Samples for each experimental condition were run in
triplicate and were normalized to b-2-microglobulin to determine relative
expression levels. Primer sequences were obtained from PrimerBank (Spandi-
dos et al., 2010) except for Gls1 and Gls2, which were manually designed.
Primer sequences are listed in Table S7. Comparison of the expression of
selected metabolic genes in resting and active T cells was visualized as heat
maps with Spotfire.
Promoter Analyses
Transcription factor motifs enriched in the promoters were identified by using
the motif analysis algorithm in the PASTAA webserver (http://trap.molgen.
mpg.de/cgi-bin/pastaa.cgi). This method considers the input order of
promoters and uses a biophysical model of promoter-transcription factor
interaction to detect motifs (Roider et al., 2009). The input order was that of
decreasing fold-change in expression and default settings of the server were
used.
Metabolic Assays
Glycolytic flux was determined bymeasuring the detritiation of [3-3H]-glucose.
Fatty acid b-oxidation flux was determined by measuring the detritiation of
[9,10-3H]-palmitic acid. Glutamine oxidation flux was determined by the rate
of 14CO2 released from [U-
14C]-glutamine. Pyruvate oxidation flux was deter-
mined by the rate of 14CO2 released from [2-
14C]-pyruvate. Glucose oxidation
flux through the pentose phosphate pathway (PPP) was determined as previ-
ously described with somemodifications described in the Supplemental Infor-
mation. Respiration was measured in intact T cells with the Seahorse XF24
analyzer. Metabolomic profiling was performed by Metabolon (Durham, NC).
Metabolic flux analysis of 13C-glutamine in active T cells was determined by
LC-MS.
Statistical Analysis
p values were calculated with Student’s t test. p values < 0.05 were considered
significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and seven tables and can be found with this article online at
doi:10.1016/j.immuni.2011.09.021.
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